Tectonic Therapeutic Shares Outstanding History (TECX)
Tectonic Therapeutic reported 18.7M shares outstanding at the end of fiscal 2025.
View full Tectonic Therapeutic company overviewTectonic Therapeutic annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 18.7M | 3.9M | +26.13% |
| 2024 | 2024-12-31 | 14.9M | 13.4M | +955.32% |
| 2023 | 2023-12-31 | 1.4M | −21.9M | −93.95% |
| 2022 | 2022-12-31 | 23.3M | 139,920 | +0.60% |
| 2021 | 2021-12-31 | 23.1M | 0 | 0.00% |
| 2020 | 2020-12-31 | 23.1M | 6.4M | +37.95% |
| 2019 | 2019-12-31 | 16.8M | 4.2M | +32.92% |
| 2018 | 2018-12-31 | 12.6M | 11.4M | +932.75% |
| 2017 | 2017-12-31 | 1.2M | — | — |
Tectonic Therapeutic quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 19.2M | 523,083 | +2.80% |
| Q1 2026 | 2026-03-31 | 18.8M | 159,207 | +0.85% |
| Q4 2025 | 2025-12-31 | 18.7M | 3.9M | +26.13% |
| Q3 2025 | 2025-09-30 | 18.7M | 4.0M | +26.92% |
| Q2 2025 | 2025-06-30 | 18.7M | 4.0M | +27.00% |
| Q1 2025 | 2025-03-31 | 18.7M | −5.1M | −21.51% |
| Q4 2024 | 2024-12-31 | 14.9M | −8.8M | −37.23% |
| Q3 2024 | 2024-09-30 | 14.7M | −8.9M | −37.57% |
| Q2 2024 | 2024-06-30 | 14.7M | −8.7M | −37.26% |
| Q1 2024 | 2024-03-31 | 23.8M | 420,820 | +1.80% |
| Q4 2023 | 2023-12-31 | 23.7M | 391,140 | +1.68% |
| Q3 2023 | 2023-09-30 | 23.6M | 416,050 | +1.79% |
| Q2 2023 | 2023-06-30 | 23.5M | 324,360 | +1.40% |
| Q1 2023 | 2023-03-31 | 23.4M | 207,760 | +0.90% |
| Q4 2022 | 2022-12-31 | 23.3M | 139,920 | +0.60% |
| Q3 2022 | 2022-09-30 | 23.2M | 74,730 | +0.32% |
| Q2 2022 | 2022-06-30 | 23.2M | 38,690 | +0.17% |
| Q1 2022 | 2022-03-31 | 23.2M | 1.0M | +4.62% |
| Q4 2021 | 2021-12-31 | 23.1M | 1.1M | +5.01% |
| Q3 2021 | 2021-09-30 | 23.1M | 3.8M | +19.71% |
| Q2 2021 | 2021-06-30 | 23.1M | 3.8M | +19.74% |
| Q1 2021 | 2021-03-31 | 22.1M | 3.1M | +15.98% |
| Q4 2020 | 2020-12-31 | 22.0M | 5.3M | +31.37% |
| Q3 2020 | 2020-09-30 | 19.3M | 2.6M | +15.32% |
| Q2 2020 | 2020-06-30 | 19.3M | 6.5M | +51.20% |
| Q1 2020 | 2020-03-31 | 19.1M | 6.4M | +50.33% |
| Q4 2019 | 2019-12-31 | 16.8M | 4.2M | +32.92% |
| Q3 2019 | 2019-09-30 | 16.8M | 4.2M | +33.03% |
| Q2 2019 | 2019-06-30 | 12.8M | 197,816.14 | +1.57% |
| Q1 2019 | 2019-03-31 | 12.7M | 11.5M | +939.15% |
| Q4 2018 | 2018-12-31 | 12.6M | — | — |
| Q3 2018 | 2018-09-30 | 12.6M | — | — |
| Q2 2018 | 2018-06-30 | 12.6M | — | — |
| Q4 2017 | 2017-12-31 | 1.2M | — | — |
Tectonic Therapeutic shares outstanding trends
Over the last five reported fiscal years, Tectonic Therapeutic's shares outstanding moved from 23.1M to 18.7M, a change of −4.4M. The latest reported quarter, Q2 2026, shows 19.2M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tectonic Therapeutic filings at SEC.gov ↗